Pegylated interferon alfa and ribavirin for 14 versus 24 weeks in patients with hepatitis C virus genotype 2 or 3 and rapid virological response. / Dalgard, Olav; Bjøro, Kristian; Larsen, Helmer Ring; Bjornsson, Einar; Holberg-Petersen, Mona; Skovlund, Eva; Reichard, Olle; Myrvang, Bjørn; Sundelöf, Bo; Ritland, Ståle; Hellum, Kjell; Frydén, Aril; Florholmen, Jon; Verbaan, Hans.
In:
Hepatology, Vol. 47, No. 1, 2008, p. 35-42.
Research output: Contribution to journal › Journal article › Research › peer-review